Christian Antoni

Opinion Author

Christian Antoni, M.D., Ph.D., is the chief medical officer at Montai Therapeutics. A rheumatologist by training, Antoni has spent his career delivering essential new drugs in chronic autoimmune diseases, including Dupixent, Kevzara and Cosentyx.

Drug development powered by artificial intelligence is countering incentives from the Inflation Reduction Act and making small molecules more attractive in the complex inflammatory & immunology disease space.